The gene encoding methylthioadenosine phosphorylase (MTAP), the initial enzyme in the methionine salvage pathway, is deleted in a variety of human tumors and acts as a tumor suppressor gene in cell culture (1-6). Overexpression of the polyamine biosynthetic enzyme ornithine decarboxylase (ODC) is frequently observed in tumors and has been shown to be tumorigenic in vitro and in vivo (7-9). In this paper, we demonstrate a novel regulatory pathway in which the methionine salvage pathway products inhibit ODC activity. We show that in 
Summary
The gene encoding methylthioadenosine phosphorylase (MTAP), the initial enzyme in the methionine salvage pathway, is deleted in a variety of human tumors and acts as a tumor suppressor gene in cell culture (1) (2) (3) (4) (5) (6) . Overexpression of the polyamine biosynthetic enzyme ornithine decarboxylase (ODC) is frequently observed in tumors and has been shown to be tumorigenic in vitro and in vivo (7) (8) (9) . In this paper, we demonstrate a novel regulatory pathway in which the methionine salvage pathway products inhibit ODC activity. We show that in Expression of MTAP in MTAP deleted MCF-7 breast adenocarcinoma cells results in a significant reduction of ODC activity and reduction in polyamine levels. Taken together, our results show that products of the methionine salvage pathway regulate polyamine biosynthesis, and suggest that MTAP deletion may lead to ODC activation in human tumors.
INTRODUCTION
A quarter century ago, Toohey first recognized that certain murine malignant hematopoietic cell lines lacked methylthioadenosine phosphorylase (MTAP) activity (10) . MTAP is a key enzyme in the methionine salvage pathway (see Figure 1 ). This pathway functions to salvage methylthioadenosine (MTA), which is formed as a byproduct of polyamine metabolism.
Phosphorolysis of MTA by MTAP results in the conversion of MTA into adenine and methylthioribose-1-phosphate (MTR1P). A series of reactions then salvages the methyl-thio group from MTR1P to form methionine. This pathway has been most extensively studied in Klebsiella pneumoniae (11) (12) (13) (14) , but has also been shown to exist in rat liver (15) (16) (17) 
and in
Saccharomyces cerevisiae (18, 19) .
Loss of MTAP activity through gene deletion is common in many kinds of human cancers including non-small cell lung cancer, glioma, T-cell acute leukemia, bladder cancer, osteosarcoma and endometrial cancer (3, 5, (20) (21) (22) . Recently, we found that expression of MTAP in a MTAP-deleted breast adenocarcinoma cell line (MCF-7) resulted in a dramatic inhibition of tumorigenicity in vitro and in vivo, showing that MTAP can function as a tumor suppressor gene (1) . We also found that MTAP expression causes a significant decrease in intracellular polyamine levels and alters the ratio of putrescine to total polyamines. Consistent with this observation, the polyamine biosynthesis inhibitor α-difluoromethylornithine (DFMO) inhibits the ability of MTAP deficient MCF-7 cells to form colonies in soft-agar, while addition of the polyamine putrescine stimulates colony formation in MTAP expressing MCF-7 cells. These results indicate that MTAP's tumor suppressor activity may be mediated by its effect on the intracellular polyamine pools.
Polyamines are small, aliphatic amines involved in a variety of cellular processes including transcription and apoptosis (8) . The rate-limiting enzyme in the production of polyamines is ornithine decarboxylase (ODC). Elevated ODC activity has been observed in a wide variety of human and animal tumors, and overexpression of ODC in NIH/3T3 cells is sufficient to cause transformation in vitro (7, 23) . Transgenic mice overexpressing ODC in skin develop skin tumors at a high frequency (24) . These observations show that overexpression of ODC is tumorigenic.
Examination of the S. cerevisiae genome for MTAP homologues suggests that the MEU1 gene, with 35% identity and 53% similarity over 275 amino acids, may encode the yeast MTAP homologue. Furthermore, recent studies show that cells lacking MEU1, in combination with a mutation that allows yeast to take up methylthioadenosine, are unable to grow on medium containing MTA as the sole sulfur source (25) . MEU1 was initially identified in a screen for genes that regulate expression of the yeast ADH2 gene (26) . Overexpression of MEU1 increased ADH2 expression while deletion of MEU1 resulted in reduced ADH2 expression. At the time these experiments were published the MTAP gene had not yet been identified, so the relationship between MEU1 and MTAP was unknown. These experiments demonstrate that MEU1 regulates ADH2 expression and indicate a link between MEU1 and gene regulation.
In this paper we show that MEU1 encodes yeast MTAP, and we characterize the effect of loss of MTAP in Saccharomyces cerevisiae and human tumor cells. Our findings show that there is a regulatory link between the methionine salvage pathway and the polyamine pathway.
Specifically, the penultimate metabolite, 4-methylthio-2-oxobutanoic acid (MTOB), acts to repress ornithine decarboxylase, the rate-limiting enzyme in polyamine biosynthesis. These results explain why MTAP deletion causes altered polyamine profiles, and suggest that MTAP's tumor suppressor activity may be due to its effect on ODC activity.
EXPERIMENTAL PROCEDURES
Plasmid pMEU1 construction -The yeast MEU1 ORF was PCR amplified from total yeast DNA using primers MEU1-1F (5′-TCT GTG AAA CAT GTC) and MEU1-1R (5′ CAG TCC CCA AGG GGG). The resulting 1.3 Kb product was the cloned into pCR2.1 (Invitrogen) and designated pCR2.1::MEU1. PCR2.1::MEU1 was digested with BamH1 and NotI and the resulting 1.3 Kb insert was cloned into pRS316 (27) digested with the same enzymes.
Yeast Strains -Yeast strains used are indicated in Table 1 . Isogenic MEU1 and meu1∆ strains were created by transformation of AS3-2a (a ura3∆ met15∆ meu1∆::LEU2 leu2∆) with pMEU1 or empty vector pRS316. All other strains used were created by the S. cerevisiae deletion project (28) .
Standard yeast growth media was used as described by Sherman (29) . Polyamine free media was prepared as described by Balasundaram (30) .
Mammalian Cells -MTAP expressing and mutant expressing MCF-7 cells were created and grown as previously described (1) . MIA PaCa-2 pancreatic adenocarcinoma cells were obtained from the ATCC and grown as previously described (31) .
Yeast Growth Studies -Yeast cells were grown to stationary phase and then diluted to an OD 600 of 0.05 in the indicated media. Cells were then grown in liquid media with shaking at 30 o C for 48 hours, at which time OD was determined.
Extract preparation -Yeast cultures (45 ml) were grown aerobically to an OD 600 of 0.5-1.0, pelleted, washed with 0.9ml of lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 1 mM PMSF), and resuspended in 750µl lysis buffer. Glass beads (0.5 mm, one-half weight of the cell pellet)
were then added to make up approximately 50-70% of total volume. Cells were lysed by using a BeadBeater at 4°C with maximum speed (4500 rpm) for 1 minute three times and kept on ice between pulses (Biospec Products). After lysis, the tubes were centrifuged for 4 minutes and the supernatant was transferred to a new tube and glycerol was added to a final concentration of 15%. The protein concentration of yeast extracts was determined by the Coomassie Blue protein assay reagent (Pierce) using bovine serum.
Mammalian cell lysates were prepared by 3 cycles of freeze-thawing at -80°C in 20 mM KH 2 PO 4 , pH 7.4 containing 1 mM phenylmethylsulfonyl fluoride (Sigma) and 1 mM dithiothreitol (Sigma).
Western blot analysis Forty µg of extract were run on pre-made 7% NuPage Tris-acetate SDS gels (Invitrogen) and electrotransferred to PVDF membrane (Biorad) using a standard protocol (32) . Samples were probed with a 1/10,000 dilution of yeast anti-ornithine decarboxylase antiserum raised in rabbits (a generous gift from Martin Hoyt and Phil Cofino, UCSF). Secondary antibody anti-rabbit HRP linked antibody was obtained from Amersham
Biosciences and used at a 1/3,000 dilution. The antibody-Antigen complex was visualized on photographic film after treatment with SuperSignal West Dura Extended Duration Substrate (Pierce biotechnology). MTAP activity in yeast extracts was determined using a spectrophotometric assay as described previously (1) . One unit of MTAP activity is defined as the amount that catalyzes the formation of 1µmol of adenine/min.
Measurement of ornithine decarboxylase, MTAP, and AdoMet decarboxylase activity

Measurement of intracellular polyamine levels by using HPLC -Yeast cells grown in
synthetic complete media were collected, protein extracts were prepared, and then 100µl supernatant added to 100µl 0.6N PCA and allowed to sit on ice for 5 minutes. The sample was centrifuged at 15,000g for 10 min. 100µl of supernatant was dansylated and analyzed by HPLC as described (35) .
RESULTS
MEU1 encodes MTAP in S.
cerevisiae -Early studies showed that yeast extracts contain MTAP activity, but did not identify the gene encoding the activity (18, 19) . A BLAST search of the S. cerevisiae genome with human MTAP (NP_002442) reveals two open reading frames, YLR209C and YLR017W, with significant sequence similarity. Of the two, YLR017W (also known as MEU1) has the most similarity with 35% identity over 275 amino acids to human MTAP. To test the possibility that MEU1 encoded MTAP, we constructed isogenic MEU1 and meu1∆ strains and measured MTAP activity in whole cell extracts (see Materials and Methods).
We found that MEU1 yeast extracts contained 0.38 units of MTAP activity, while extracts from meu1∆ strain had no detectable activity (<0.01units). A second experiment to confirm our hypothesis involved examining the growth of isogenic meu1∆ and MEU1 strains with auxotrophic markers for adenine and methionine in media in which MTA had been substituted for methionine and adenine. We found that wild-type but not meu1∆ yeast can grow using methylthioadenosine (MTA) as a substitute for methionine and adenine ( Figure 2 ). Taken together, these observations show that MEU1 encodes yeast MTAP.
Effect of meu1∆ on polyamine pools and ODC activity
Since MTA is a by-product of polyamine production, we suspected that cells lacking MTAP might have altered polyamine pools due to end-product inhibition. Therefore, we measured the intracellular level of polyamines (putrescine, spermine and spermidine) in an isogenic wild-type strain and in a meu1∆ strains using HPLC (see Materials and Methods). We found that in synthetic complete media, MEU1 cells had undetectable levels of putrescine, while meu1∆ cells contained at least a 20-fold increase in putrescine (Figure 3a) . Surprisingly, we also found that spermidine levels were significantly increased and that the total polyamine content of meu1∆ cells was more than twice that of isogenic wild-type yeast (62 vs. 28 nmoles/mg).
To explain the overall elevation in polyamine levels we examined ornithine decarboxylase (ODC) activity in wild type and meu1∆ yeast. ODC is the rate-limiting enzyme in polyamine production and is regulated at the post-transcriptional level (36) . We found that cell extracts from meu1∆ yeast had an eight-fold increase in ODC activity compared to isogenic wild-type yeast (Figure 3b) . This difference appeared to be due to elevated levels of ODC protein. We were unable to detect ODC protein by immunoblot in extracts derived from MEU1 cells as has been previously observed (37) and from ODC deficient cells (spe1∆), but we saw substantial expression in meu1∆ extracts (Figure 4a, lanes 1-3) . The increase in protein levels appeared to be even greater then the measured activity, suggesting that not all of the protein was active (lanes 1 and 2). We also noticed that meu1∆ yeast formed significantly larger colonies compared to isogenic MEU1 yeast on polyamine free media, suggesting that the elevated ODC is important for growth under theses conditions (Figure 4b ). These results show that MEU1 represses ODC expression and activity.
We also examined the effect of MEU1 on S-adenosylmethionine decarboxylase (SAMDC) activity. We found that extracts from meu1∆ cells had twice the SAMDC activity of isogenic MEU1 (7.7 ± 0.3 vs. 14.6 ± 0.8 nmol/mg/hr). This result is consistent with the idea that MEU1 acts to repress polyamine synthesis.
SPE2 and MEU1 regulate ODC through different mechanisms -Previous work has shown
that mutations in SPE2, encoding SAM decarboxylase, also cause a dramatic increase in ODC protein levels (36) (also Figure 3a, lane 4) . It was also shown that the ODC overexpression observed in a spe2 mutant could be suppressed by the addition to spermidine to the media. We compared ODC expression in spe2∆ and meu1∆ strains in the presence and absence of spermidine. Meu1∆, spe2∆ and meu1∆/spe2∆ double mutants were grown in polyamine free medium with or without the addition of exogenous spermidine. When we measured ODC enzyme activity we found that addition of 0.1 mM spermidine to the media caused a 416% decrease in ODC activity in spe2∆ cells, but only a 15% decrease in meu1∆ cells (Figure 5a ).
The double mutant strain had an intermediate phenotype, with a 52% decrease. Differential response to spermidine was also observed at the protein level as shown by immunoblot analysis (Figure 5b ). In the spe2∆ strain addition of spermidine resulted in undetectable levels of ODC, while it had no detectable effect on meu1∆ strain. These results show that elevation of ODC levels in meu1∆ strains and in spe2∆ strains are due to different regulatory systems.
MTA has no effect on ODC protein levels MTA, the substrate of MTAP, is known to be a strong competitive inhibitor of spermine synthase, SAH hydrolase, and other methyltransferases (38) (39) (40) . We tested the possibility that elevated MTA levels could cause the elevation of ODC levels we observed in meu1∆ yeast. We grew cultures of MEU1, meu1∆, and spe2∆ yeast with and without added 5 mM MTA to media, and examined ODC protein by immunoblot ( Figure   5c ). We saw no significant increase in ODC levels of any of the three strains by the addition of exogenous MTA. This result indicates that build-up of MTA is not responsible for the elevated ODC levels observed in meu1∆ yeast.
Mutations in E1 and E2 homologues effect ODC and polyamine levels -Given the result above,
we reasoned that a salvage pathway metabolite downstream of MTA might play a key role in repressing ODC levels. To test this hypothesis, we examined ODC levels in yeast strains deleted for genes similar to two known salvage pathway enzymes from Klebsiella oxytoca. The E1 protein from Klebsiella catalyzes the conversion of 2,3-diketo-5-methylthio-1-phosphopentene to 1,2-dihydroxy-3-keto-5-methylthiopentene, while the E2 protein catalyzes the subsequent formation of 2-keto-4-methylthiobutyrate (see Figure 1) (6, (41) (42) (43) . We searched the S. cerevisiae genome for ORFs similar to these proteins and found one for each gene. Yeast YEL038W encodes a protein that is 37% identical to Klebsiella E1, while yeast YMR009W encodes a protein with 26% identity to E2. We obtained deletions of each of these genes from the Saccharomyces Genome Deletion Project (28) . Deletion strains for each of these proteins were viable and whole cell extracts were prepared and examined for polyamine levels, ODC activity, and protein levels. E1 and E2 deletion strains had elevated ODC activity and protein levels compared to the MEU1 control strain (see Figure 3b and Figure 4a ). However, neither strain had quite the same level of induction as observed in the meu1∆ strain. The polyamine profiles also showed an intermediate effect (Figure 3a) .
Spermidine levels were clearly elevated in the E1 and E2 mutants, but putrescine was still below the limit of our detection. These results show that mutations in enzymes downstream of MTAP cause elevated ODC levels and elevated levels of spermidine.
MTOB repression of ODC in meu1∆
Based on the findings above and our knowledge of the biochemical pathway, we reasoned that perhaps MTOB was a negative regulator of ODC. We tested this hypothesis by growing the various mutants in media in which 1 mM MTOB was substituted for methionine. Yeast grown in MTOB had identical doubling times as yeast grown in methionine (data not shown). However, immunoblot analysis of ODC clearly shows that the addition of MTOB dramatically abolishes the elevated ODC levels observed in meu1, E1, and E2 mutants ( Figure 6 ). This finding shows that MTOB represses ODC protein levels.
MTAP and MTOB repress ODC in human tumor cells -Previously we have described the
creation of isogenic MTAP positive and MTAP negative MCF-7 breast adenocarcinoma cell lines, and showed that MTAP caused a three-fold decrease in total polyamine levels (see Table 3 We found in S. cerevisiae that mutations in the homologues from Klebsiella E1 and E2 had more modest effects on ODC activation than MTAP deletion. If MTOB were the only inhibitor of ODC, one would expect levels to be identical. There are two possible explanations. First, it may be that there are alternate enzymatic pathways in yeast that can convert methylthioribose-1-phosphate to MTOB, and thus the E1 and E2 mutants may have some low level of MTOB present. Consistent with this idea, Dibner et al. reported that methylthioribose-1-phosphate could be converted to 2-hydroxy-4-methylthiobutanoic acid which could then be converted to MTOB (47) . Alternatively, other metabolites in the pathway may also inhibit ODC levels. For example, MTOB and methylthioribose-1-phosphate may both be repressors of ODC.
In this paper we show several lines of evidence that the yeast MEU1 gene encodes MTAP, including amino acid similarity, requirement of MEU1 for enzyme activity, and growth on MTA containing media. The MEU1 gene was initially identified in a genetic screen designed to isolate mutations affecting transcriptional regulation of ADH2 (26) . Why did MTAP come up in such a screen? Our finding that MTAP deletion alters polyamine homeostasis by overexpression of ODC suggests a possible explanation. Recent evidence indicates that there is a significant link between polyamines, enzymes involved in chromatin remodeling, and transcriptional regulation. In yeast it has been found that mutations that reduce polyamine levels are able to bypass the need for the core histone deacetylase, GCN5, for the expression of certain genes (48) . In ODC over-expressing transgenic mice both intrinsic histone acetyltransferase (HAT) and deacetylase activities (HDAC ) are elevated (49, 50) . Alterations in HAT and HDAC activities would be expected to have effects on a large number of genes (51 ODC levels in yeast and mammalian cells are regulated post-transcriptionally. In higher cells, the antizyme protein targets ODC for degradation by the proteosome (52) . Antizyme production requires a frame-shifting event that is greatly stimulated when polyamines are absent. S. cerevisiae lacks a canonical antizyme, but appears to have a similar post-transcriptional mechanism for ODC regulation in response to polyamine depletion (36) . Our work here shows that the salvage pathway products also negatively regulate ODC. Thus ODC is feed-back regulated by both of its downstream pathways. We did not observe a "hyper" increase in the ODC levels in the double mutant suggesting that both feedback processes may be affecting the same underlying mechanism, i.e. disruption of either feedback loop results in elevated ODC.
Our findings also support our earlier hypothesis that MTAP acts as a tumor suppressor by altering polyamine pools. Previously, our lab has shown that expression of MTAP in MTAP deleted MCF-7 cells suppresses anchorage-independent growth, tumor formation in SCID mice, and causes significant reduction in polyamine levels (1) . This reduction in polyamines is easily explained by inhibition of ODC by MTAP. We also demonstrated in our previous work that addition of putrescine could partially restore anchorage-independent growth to MTAP expressing cells, indicating that at least part of MTAP's ability to suppress tumorigenicity is due to its affect on polyamine production. However, it is possible that MTAP deletion in tumor cells may be affecting other pathways in addition to polyamine biosynthesis that contribute to tumorigenicity. Future experiments will focus on answering this question. Extracts were prepared and analyzed as above. 
